Container device
Latest AstraZeneca AB Patents:
- Pharmaceutical composition
- Methods of treating chronic kidney disease with dapagliflozin
- Pharmaceutical compositions comprising (2S)-n-{(1S)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
- Arginase inhibitors and methods of use thereof
- Conjugates comprising cleavable linkers
The device relates to a container for holding tablets or the like. The container comprises a hollow body which holds the content, a closure that cooperates with the body to close the container, and a compliance aid device arranged on the container for indicating the time at which the last dose was taken or when the next dose is due.
Claims
The ornamental design for a container device, as shown and described.
191503 | May 1877 | Wiseman |
2636469 | April 1953 | McKay |
3735099 | May 1973 | Herr |
4535903 | August 20, 1985 | Franchi |
4971203 | November 20, 1990 | Weinstein |
D344889 | March 8, 1994 | Kozlowski et al. |
5372267 | December 13, 1994 | Hofmann |
5683008 | November 4, 1997 | Galer |
D397247 | August 25, 1998 | Gardner et al. |
5908125 | June 1, 1999 | Opresco |
6082572 | July 4, 2000 | Galton-Fenzi et al. |
D515804 | February 28, 2006 | Chue |
D516420 | March 7, 2006 | Teo |
D528288 | September 19, 2006 | Coe et al. |
D540162 | April 10, 2007 | Chin et al. |
20060124501 | June 15, 2006 | McNeely |
20070170191 | July 26, 2007 | Arvidsson et al. |
609954 | July 1998 | EP |
998 148 | July 1965 | GB |
WO 2004/041671 | May 2004 | WO |
- U.S. Appl. No. 29/278,455, filed Mar. 30, 2007, Arvidsson et al.
- U.S. Appl. No. 11/755,105, filed May 30, 2007, Arvidsson et al.
- U.S. Appl. No. 11/624,314, filed Jul. 26, 2007, Arvidsson et al.
Type: Grant
Filed: Mar 30, 2007
Date of Patent: Oct 14, 2008
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Lars Arvidsson (Lund), Lena Axelson-Larsson (Södertälje), Per Frid (Lund)
Primary Examiner: Catherine R Oliver
Attorney: White & Case LLP
Application Number: 29/278,449